Heart failure in the course of a pandemic

Farmakis, Dimitrios; Mehra, Mandeep R.; Parissis, John; Filippatos, Gerasimos

doi:10.1002/ejhf.1929

Cited by 5 publications

(6 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 37 , 38 Limitations in access to care were only partly counterbalanced by use of telehealth. 37 , 39 , 40 …”

Section: Morbidity and Mortality Of Patients With Heart Failure During The Covid ‐19 Pandemicmentioning

confidence: 99%

“…Indeed, during the lockdown, psychological distress, diminished well‐being, an increase in unhealthy lifestyle behaviours and an augmentation of HF symptoms were common in patients with HF and at the same time challenged the capacity for comprehensive supportive, and evidence‐based care 37,38 . Limitations in access to care were only partly counterbalanced by use of telehealth 37,39,40 …”

Section: Morbidity and Mortality Of Patients With Heart Failure Durin...mentioning

confidence: 99%

“…37,38 Limitations in access to care were only partly counterbalanced by use of telehealth. 37,39,40 Fear of contracting the virus has led to substantial increases in the time from symptom onset in patients with worsening HF to seeking medical care, leading to a presentation at a more advanced stage. At the beginning there were also concerns by the medical society regarding the mechanism of action of angiotensinconverting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which were linked with SARS-CoV-2 pathophysiology, given that the ACE2 enzyme is the functional receptor for the viral spike protein.…”

Section: Morbidity and Mortality Of Patients With Heart Failure Durin...mentioning

confidence: 99%

See 2 more Smart Citations

COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

Rosano

Jankowska

Ray

et al. 2021

European J of Heart Fail

Self Cite

View full text Add to dashboard Cite

Patients with heart failure (HF) who contract SARS‐CoV‐2 infection are at a higher risk of cardiovascular and non‐cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID‐19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID‐19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID‐19 vaccination scheme in patients with HF. COVID‐19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID‐19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID‐19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS‐CoV‐2 infection (including the COVID‐19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF.

show abstract

“… 37 , 38 Limitations in access to care were only partly counterbalanced by use of telehealth. 37 , 39 , 40 …”

Section: Morbidity and Mortality Of Patients With Heart Failure During The Covid ‐19 Pandemicmentioning

confidence: 99%

Section: Morbidity and Mortality Of Patients With Heart Failure Durin...mentioning

confidence: 99%

Section: Morbidity and Mortality Of Patients With Heart Failure Durin...mentioning

confidence: 99%

See 1 more Smart Citation

COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

Rosano

Jankowska

Ray

et al. 2021

European J of Heart Fail

Self Cite

View full text Add to dashboard Cite

show abstract

“…The prevalence of heart failure is increasing, and optimal physical and medical prophylactic and therapeutic strategies are still to be determined. 1 – 3 Of note, the management of pulmonary congestion is important to improve mortality and morbidity, as well as patients’ quality of life. 4 In addition to appropriate diuretic therapy, appropriate body posture helps prevent worsening heart failure.…”

mentioning

confidence: 99%

Relationship Between Body Posture and Lung Fluid Volume Assessed Using a Novel Noninvasive Remote Dielectric Sensing System

et al. 2022

View full text Add to dashboard Cite

demonstrated a correlation between ReDS values and lung fluid levels, 8,9 as well as the clinical implications of ReDSguided heart failure management. 10, 11 The Second Department of Internal Medicine, Toyama University received permission to use the device for the first time in Japan before commercial marketing. The device itself will soon be clinically available in Japan.In the present proof-of-concept study, we investigated the relationship between body posture and ReDS values in healthy volunteers to clarify the physiological proof of fluid shift depending on different body postures. Methods Participant SelectionHealthy volunteers aged >20 years without any past medical history were prospectively included in this single-center proofof-concept study between August and September 2021. This study was approved by the Clinical Research Review Board, University of Toyama (IRB no. MTK2020007), and written informed consent was obtained from all participants.

show abstract

“…HF is a major economic burden for healthcare systems, accounting for 1–2% of the total healthcare expenditure in the EU and the USA [ 2 ]. Notably, the COVID-19 pandemic has accelerated these trends due to heart damage associated with infection [ 3 ], causing disruption to healthcare services, which has had a negative impact on prevention and efforts to delay progression.…”

Section: Introductionmentioning

confidence: 99%

Prediction and Analysis of Heart Failure Decompensation Events Based on Telemonitored Data and Artificial Intelligence Methods

Kerexeta

Larburu

Escolar

et al. 2023

JCDD

View full text Add to dashboard Cite

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Heart failure (HF) occurs when the heart is not able to pump enough blood to satisfy metabolic needs. People diagnosed with chronic HF may suffer from cardiac decompensation events (CDEs), which cause patients’ worsening. Being able to intervene before decompensation occurs is the major challenge addressed in this study. The aim of this study is to exploit available patient data to develop an artificial intelligence (AI) model capable of predicting the risk of CDEs timely and accurately. Materials and Methods: The vital variables of patients (n = 488) diagnosed with chronic heart failure were monitored between 2014 and 2022. Several supervised classification models were trained with these monitoring data to predict CDEs, using clinicians’ annotations as the gold standard. Feature extraction methods were applied to identify significant variables. Results: The XGBoost classifier achieved an AUC of 0.72 in the cross-validation process and 0.69 in the testing set. The most predictive physiological variables for CAE decompensations are weight gain, oxygen saturation in the final days, and heart rate. Additionally, the answers to questionnaires on wellbeing, orthopnoea, and ankles are strongly significant predictors.

show abstract

Heart failure in the course of a pandemic

Abstract: This article refers to 'Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology' by Y. Zhang et al.,

Cited by 5 publications

References 28 publications

COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

Relationship Between Body Posture and Lung Fluid Volume Assessed Using a Novel Noninvasive Remote Dielectric Sensing System

Prediction and Analysis of Heart Failure Decompensation Events Based on Telemonitored Data and Artificial Intelligence Methods

Contact Info

Product

Resources

About